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OBJECTIVE — Gestational diabetes mellitus (GDM) may cause obesity in the offspring. The
objective was to assess the effect of treatment for mild GDM on the BMI of 4- to 5-year-old
children.
RESEARCH DESIGN AND METHODS — Participants were 199 mothers who partic-
ipatedinarandomizedcontrolledtrialofthetreatmentofmildGDMduringpregnancyandtheir
children. Trained nurses measured the height and weight of the children at preschool visits in a
state-wide surveillance program in the state of South Australia. The main outcome measure was
age- and sex-speciﬁc BMI Z score based on standards of the International Obesity Task Force.
RESULTS — At birth, prevalence of macrosomia (birth weight 4,000 g) was 5.3% among
the 94 children whose mothers were in the intervention group, and 21.9% among the 105
childrenintheroutinecarecontrolgroup.At4-to5-years-old,mean(SD)BMIZscorewas0.49
(1.20) in intervention children and 0.41 (1.40) among controls. The difference between treat-
ment groups was 0.08 (95% CI 0.29 to 0.44), an estimate minimally changed by adjustment
formaternalrace,parity,age,andsocio-economicindex(0.08[0.29to0.45]).EvaluatingBMI
85th percentile rather than continuous BMI Z score gave similarly null results.
CONCLUSIONS — AlthoughtreatmentofGDMsubstantiallyreducedmacrosomiaatbirth,
it did not result in a change in BMI at age 4- to 5-years-old.
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I
n animal models, experimentally in-
duced gestational diabetes mellitus
(GDM) causes increased offspring adi-
posity. If the offspring is female, she is
likely to develop GDM herself when she
becomes pregnant, perpetuating an inter-
generational vicious cycle of diabetes and
obesity (1,2). Given that obesity and dia-
betesareepidemicinthedevelopedworld
and emerging rapidly as primary threats
to health in the developing world (3), this
sequence—if it also occurs in human
populations—could have major adverse
effects on health for some time to come.
Interrupting the cycle would be a public
health imperative.
The extent to which these inﬂuences
actually operate in human populations,
however, is not known. Evaluating
whether GDM causes obesity in even one
subsequent generation is challenging.
Observational studies showing that dia-
betes during pregnancy is associated with
higher offspring BMI emanate predomi-
nantly from populations with high preva-
lences of obesity and diabetes (4,5).
Generalpopulationsamples,inwhichthe
average severity of GDM is milder, typi-
cally yield more modest or null associa-
tions (6,7). One hypothesis for these
differences across studies is that effective
treatment of mild GDM reduces the risk
of obesity in the child. In a U.S. managed
carepopulation,Hillieretal.(8)foundan
almost twofold increased risk of elevated
weight at 5- to 7-years-old among chil-
drenwhosemothershaduntreatedGDM,
whereas the association with treated
GDM was weaker, similar to that of the
milder impaired glucose tolerance.
While observational studies can raise
the hypothesis that treatment of GDM
mitigates an otherwise high risk of child
obesity, only a randomized controlled
trial can address this hypothesis in an un-
confounded manner. No such studies ex-
ist. The aim of this study was to examine
the effect of the treatment of GDM on the
BMI of 4- to 5-year-old children whose
mothers participated in a randomized
controlled trial of treatment for mild
GDM in pregnancy. To achieve this aim,
we took advantage of the temporal and
geographic co-existence of a randomized
controlled trial and a child height/weight
surveillance system. Given that the ran-
domized intervention resulted in lower
weight at birth, and that lower birth
weight is associated with lower BMI in
childhood (9), we hypothesized that the
intervention would also result in lower
BMI at age 4- to 5-years-old.
RESEARCH DESIGN AND
METHODS
Subjects and measurements
The Australian Carbohydrate Intolerance
StudyinPregnantWomen(ACHOIS)was
a multi-center randomized controlled
trial of treatment of mild GDM. From
1993 to 2003, the investigators randomly
allocated women who had mild GDM be-
tween 24 and 34 weeks’ gestation to an
intervention group consisting of dietary
advice,bloodglucosemonitoring,andin-
sulin therapy if necessary, or to a routine
care control group. Approximately 20%
of the intervention participants received
insulin. The intervention reduced serious
perinatalcomplicationsfrom4to1%,and
it reduced the prevalence of macrosomia
(birth weight 4,000 g) from 21 to 10%
(10). Just over half of the 1,000 mothers
who participated in the trial lived in the
state of South Australia.
South Australia’s Children, Youth
and Women’s Health Service (CYWHS
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2004) provides a range of health and so-
cial services and programs for parents,
children, and young people across the
state. As part of these services, child and
family health nurses have performed
healthcheckson4-to5-year-oldchildren
atallkindergartensandpreschoolcenters
since 1995. During these visits, they have
used a standard protocol to measure
height with a ﬁxed tape and weight of
children dressed in underwear, and they
have recorded the data electronically
(11). From 1997 through 2007, the pe-
riod of child follow-up in this study, the
average participation rate was 65% of
South Australian children. To merge the
ACHOIS trial data with the CYWHS sur-
veillance data, we used the child’s date of
birth, sex, name, and address as the link-
ingvariables.Werequiredanexactmatch
for all four variables.
There were 526 mothers of 542 chil-
dren from South Australia that partici-
pated in the ACHOIS trial. Two stillbirths
occurred in this group leaving 524 moth-
ers of 540 children for follow-up. Given
that CYWHS nurses measured preschool
height and weight on 65% of the chil-
dren in the state, 351 (65% of 540)
were eligible for inclusion in this study.
Throughthelinkingprocess,weobtained
height and weight data at 4- to 5-years-
old on 241 children, among whom 29
weightmeasurementsweremissingand1
(162 kg) was implausible. We further ex-
cluded the 6 pairs of twins leaving a sam-
ple for analysis of 199 mothers and their
singleton children representing 60% of
eligible children. Figure 1 shows partici-
pant ﬂow by treatment group.
Data analysis
The outcome variable was BMI, calcu-
lated as child’s weight (kg) divided by the
square of height (m). We expressed BMI
as continuous Z score based on age- and
sex-speciﬁcstandardsoftheInternational
Obesity Task Force (12). We ﬁrst exam-
ined simple differences in BMI-Z by treat-
ment group, then used multiple linear
regression analysis to adjust for poten-
tially confounding maternal and child co-
variates. In secondary analyses, we used
multivariable log binomial regression to
examine the effects of treatment on a di-
chotomousoutcome,BMIatorexceeding
the age- and sex-speciﬁc 85th percentile.
Wereportedregressionestimatesorprev-
alenceriskratios(relativerisk)alongwith
95% CIs. We used SAS version 9.2 (Cary,
NC).
Ethics
Through the linkage of the two data
sources, we created a de-identiﬁed data-
set.TheHumanResearchEthicsCommit-
tee of CYWHS approved the protocol.
The researchers were independent of the
funders.Thesponsorsofthestudyhadno
roles in study design; collection, analysis,
and interpretation of data; writing the ar-
ticle; or the decision to submit it for
publication.
RESULTS— Among the 199 partici-
pating mothers, the distributions of fac-
tors according to treatment group at trial
baseline were similar to those among the
524 eligible South Australians and all
1,000 mothers recruited into ACHOIS
(Table 1). At birth, prevalence of macro-
somia was 5.3% among the 94 children
whose mothers were in the intervention
group and 21.9% among the 105 in the
routine care control group. A similar con-
trast was evident among all South Austra-
lian and all ACHOIS subjects (Table 1).
At4-to5-years-old,mean(SD)BMIZ
scorewas0.49(1.20)amongintervention
children and 0.41 (1.40) in the routine
care group (Table 2); 33.0 and 27.6%,
respectively, had BMI at or exceeding the
85th percentile. Because the participants’
mothers had relatively high BMI them-
selves, these estimates were higher than
the prevalence of 15.9–20.1% among the
over100,000childrenintheCYWHSsur-
veillance database for the years 1997-
2007 (13) (and unpublished CYWHS
data).
ForchildBMIZscore,theunadjusted
difference between treatment groups was
0.08 (95% CI 0.29 to 0.44). After ad-
justment for maternal race, parity, age,
and socio-economic index, the estimate
was minimally changed (0.08 [0.29 to
Figure 1—Participants in a study assessing BMI among 4- to 5-year-old children whose mothers
participated in a randomized controlled trial of treatment of mild gestational diabetes.
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BMI exceeding the 85th percentile. For
this outcome, the multivariable adjusted
relative risk for treated versus untreated
GDM was 1.17 (0.77–1.78), which was
marginally different from the unadjusted
estimate (Table 2).
Data on maternal BMI at trial entry in
early pregnancy were available for a total
of 178 mother-child pairs. Additional ad-
justment for this variable did not materi-
allychangetheestimatesforthetreatment
effects on either child outcome, BMI Z
score, or BMI 85th percentile (data not
shown).
CONCLUSIONS— In this follow-up
study of children whose mothers partici-
patedinarandomizedcontrolledtrial,we
did not ﬁnd that treatment of mild GDM
during pregnancy reduced BMI in 4- to
5-year-olds even though macrosomia at
birth was substantially lower in the inter-
vention group than the control group.
Statistical power was adequate. The mul-
tivariable-adjustedeffectestimateforBMI
Z score was 0.08 with a lower 95% conﬁ-
dence limit of 0.29. Thus we effectively
ruled out any reduction in BMI greater
thanone-fourthtoone-thirdofSD,which
equatestoonly0.3–0.4kg/m
2(alsoabout
0.3–0.4 kg) for the average 4- to 5-year-
old boy or girl whose BMI is in the range
of 16–17 kg/m
2.
Given that animal experiments and
many observational studies suggest that
GDM may cause offspring obesity, it is
natural to wonder why the results of this
study were null. Observational studies
may overestimate treatment effects be-
cause of confounding; minimizing con-
founding is the principal reason for doing
randomized trials. Because all mothers in
ACHOIS had mild GDM, we could not
assess the effect of treatment of more se-
vere GDM, which might be necessary to
Table 1—Characteristics of participants at trial baseline in pregnancy and at birth
This study
All South Australian
subjects in ACHOIS All subjects in ACHOIS
n (children) 199 540 1,030
ICICIC
n 94 105 265 275 506 524
Maternal characteristics at trial
baseline
Mean
Age (years) 30.3 28.9 30.0 29.4 30.9 30.1
Results from oral glucose
tolerance test
Fasting glucose (mmol/l) 4.9 4.8 4.9 4.9 4.8 4.8
Median
BMI (kg/m
2) 27.7 25.3 27.4 26.5 26.8 26.0
Gestational age at entry (week) 29.5 29.7 29.4 29.7 29.1 29.2
Results from oral glucose
tolerance test
2-h glucose 8.4 8.6 8.5 8.6 8.6 8.5
%
Race
White 85.1 89.5 82.1 87.6 72.7 77.6
Asian 11.7 8.6 12.1 9.0 18.8 14.1
Aboriginal/other 3.2 1.9 5.8 3.4 8.6 8.2
Socio-economic index
Overseas 4.7 4.5
Low 48.9 34.3 45.5 39.3 31.2 24.7
Low-mid 11.7 22.9 17.5 24.0 21.6 25.1
Mid-high 26.6 22.9 23.3 21.7 21.8 22.4
High 12.8 20.0 13.6 15.0 20.6 23.3
Primiparous 44.7 43.8 48.2 46.4 43.3 49.2
Child characteristics at birth Mean
Birth weight (bw), g 3,346 3,585 3,290 3,468 3,335 3,482
%
SGA (bw 10th percentile) 9.6 6.7 9.1 7.3 6.5 7.3
LGA (bw 90th percentile) 10.6 22.9 10.2 21.1 13.4 21.9
Macrosomia (bw  4,000 g) 5.3 21.9 7.5 18.5 9.7 21.0
Sex (male) 50.0 52.4 52.1 52.7 51.4 49.8
This study comprised singleton pregnancies. In the original ACHOIS study, however, because of twin pregnancies, the number of participating mothers (524 in
SouthAustralia,1,000overall)waslowerthanthenumberofchildren.C,routinecarecontrolgroup;I,interventiongroup;LGA,largeforgestationalage,percentiles
from general population reference; SGA, small for gestational age, percentiles from general population reference.
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sibility is that postnatal factors that deter-
mine a child’s height and weight, such as
diet and physical activity, overwhelm any
effects of treating GDM during preg-
nancy. We did not have data on child be-
haviors to assess this possibility.
Alternatively, the long-term effect of
GDM on childhood obesity and its reduc-
tion through treatment may not appear
until later in childhood. In studies based
in a specialty clinic, Metzger and col-
leagues (5) observed that children of dia-
betic mothers were heavier than
population control subjects at birth, but
not at ages 1, 2, or 3 years. Only in school
age did the excess weight reappear. Like-
wise, in a study of Pima Indian sib-pairs,
associations of GDM with higher off-
spring BMI were apparent from age 9
years through early adulthood, but not at
6–9 years of age (4). Consistent with
these observations, in the pre-birth co-
hort study Project Viva, we recently re-
ported that children of mothers with
GDM had less rapid weight gain in the
ﬁrst6monthsoflifethanchildrenofnon-
diabetic mothers (14). The explanation
for the age-associated disappearance and
re-emergence of the association of GDM
with higher child weight status is un-
known. One possibility is that GDM has
differential effects on lean and fat mass in
the early years of life. In the Hyperglyce-
mia and Adverse Pregnancy Outcomes
Study, higher maternal glucose levels
were associated with the sum of skinfold
thicknesses at birth (a direct measure of
adiposity) (15). Among 3-year-old chil-
dren in Project Viva, GDM was associated
with increased systolic blood pressure
and the sum of skinfold thicknesses (a di-
rectmeasureofadiposity)butnotwithBMI,
which comprises both lean and fat mass
(16). Unfortunately, we could not directly
evaluate whether mild GDM caused higher
BMI in later childhood in the present anal-
ysisbecausetheCYWHSsurveillanceofthe
height and weight of the children does not
extend past 5 years of age.
A less likely explanation for null re-
sults is selection bias. We obtained out-
come data on fewer than half of South
Australian ACHOIS subjects. However,
differences according to treatment group
at baseline and in the newborn period
weresimilaramongparticipantsandnon-
participants, and adjustment for a range
of covariates did not materially change ef-
fectestimates.Theseobservationssuggest
that loss to follow-up did not substan-
tially bias the results.
Inaccurate outcome measurement is
also unlikely to explain the null results.
Child and family health nurses measured
height and weight with standard proto-
cols. Moreover, while nondifferential er-
ror in exposure measurement can bias
estimates toward the null value, noise in
measurement of the outcome merely
makes estimates less precise but does not
introduce bias.
It is also unlikely that the observed
effects of the ACHOIS intervention on in-
fant outcomes were the result of chance,
and that further child follow-up revealed
the fallacy. The intervention reduced the
riskofseveralnewbornmorbiditiesinad-
dition to macrosomia, including the pri-
mary outcomes of fetal and neonatal
death and birth injuries (10). Also, recent
data from a U.S.-based randomized trial
of the treatment of mild GDM showed re-
ductions in macrosomia (6 vs. 14%),
newborn fat mass, caesarean section, and
shoulder dystocia, although a composite
neonatal end point was not demonstrably
different in the intervention versus con-
trol group (17). Consistency across these
two studies suggests a real effect of GDM
treatment on important infant health
outcomes.
To conduct this study, we recognized
that routine surveillance offered a low-
cost way to obtain outcome data for re-
search studies. This type of collaboration
has the potential to increase knowledge
and improve health by combining re-
search studies, public health programs,
and surveillance activities.
Measuring health outcomes among
children whose mothers participated in
randomizedtrialsduringpregnancyisnot
only the most direct way of conﬁrming
animal experiments of prenatal program-
ming,butalsomayrevealhowtoimprove
child and adult health outcomes by inter-
vening at early stages of human develop-
ment. In this study, however, we did not
substantiate our hypothesis that treat-
ment of mild GDM during pregnancy re-
duces BMI in preschool-age children.
Studiesareneededthatinvolvelongerfol-
low-upofchildrenwhosemotherspartic-
ipated in completed randomized trials of
GDMtreatment.Moreover,anynewlyde-
signed trials of treatment or prevention of
GDM would beneﬁt from funding to fol-
low the children long term with measures
of body composition.
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